OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 7
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 7
Showing 7 citing articles:
Unveiling Microbiota Profiles in Saliva and Pancreatic Tissues of Patients with Pancreatic Cancer
Alper Uğuz, Can Müftüoğlu, Ufuk Mert, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 119-119
Open Access
Alper Uğuz, Can Müftüoğlu, Ufuk Mert, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 119-119
Open Access
The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage.
Georgios Efthymiou, Coralie Compare, Eugénie Lohmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Georgios Efthymiou, Coralie Compare, Eugénie Lohmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Berberine loaded glyceryl monooleate nanoparticles exhibited potent intrinsic anticancer activity against pancreatic cancer therapy: In vitro and in silico studies
Md. Harun Al Rashid, Sweta Mishra, Saswati Pattnaik, et al.
Nano Trends (2025), pp. 100092-100092
Open Access
Md. Harun Al Rashid, Sweta Mishra, Saswati Pattnaik, et al.
Nano Trends (2025), pp. 100092-100092
Open Access
Metabolism-Related Programmed Cell Death: Unveiling Prognostic Biomarkers, Immune Checkpoints, and Therapeutic Strategies in Ovarian Cancer
Mengdi Fu, Hao Wu, Peng Peng, et al.
Cancer Investigation (2025), pp. 1-22
Closed Access
Mengdi Fu, Hao Wu, Peng Peng, et al.
Cancer Investigation (2025), pp. 1-22
Closed Access
Identification of Novel Cyclobutane-Based Derivatives as Potent Acetyl-CoA Carboxylase Allosteric Inhibitors for Nonalcoholic Steatohepatitis Drug Discovery
Yazhou Wang, Hai Wang, Qingqing Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Yazhou Wang, Hai Wang, Qingqing Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Clinical glycoproteomics: methods and diseases
Yujia Wang, Kaixin Lei, Lijun Zhao, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 2
Yujia Wang, Kaixin Lei, Lijun Zhao, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 2
Unveiling the Resistance to Therapies in Pancreatic Ductal Adenocarcinoma
Ashu Shah, Koelina Ganguly, Sanchita Rauth, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101146-101146
Closed Access | Times Cited: 1
Ashu Shah, Koelina Ganguly, Sanchita Rauth, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101146-101146
Closed Access | Times Cited: 1
Photothermal nanocomposite reactivate “immune-hot” for triple-negative breast cancer treatment via glutamine metabolism reprograming
Yingfeng Cheng, Yanxian Hou, Zhanzheng Ye, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 245, pp. 114268-114268
Closed Access | Times Cited: 1
Yingfeng Cheng, Yanxian Hou, Zhanzheng Ye, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 245, pp. 114268-114268
Closed Access | Times Cited: 1
Unveiling the Promise: Navigating Clinical Trials 1978–2024 for PDAC
A. Domínguez, M Perz, Yi Xu, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3564-3564
Open Access | Times Cited: 1
A. Domínguez, M Perz, Yi Xu, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3564-3564
Open Access | Times Cited: 1
